Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Innovelty
    Member
    • Sep 2012
    • 14

    PolyA Enrichment Failed, Now What Do I Do?

    Apologies if this doubles. I tried to post before but it didn't seem to work.

    I've had very good success with poly(A) / mRNA enrichment on Sera-Mag Oligo-dt beads in the past. In fact, I had great success just last week. This week, it seemed to fail. I'm trying to figure out why, and if there's any hope I might rescue my samples.

    I use home-made buffers with oligo-dt beads from Sera-Mag. This time (as opposed to last time) I also used RNA Spike-Ins from ERCC. Upon Qubiting my eluted "mRNA" this morning, I determined that I recovered essentially no polyA RNA.

    Differences this time from last time:
    - I opened a new lot of beads. Is it possible the beads are bad? (I'm really hoping for this.)
    - It is possible I didn't wash off all of the Sodium azide solution, I was multi-channeling and having trouble seeing what I was doing. Would sodium azide inhibit polyA capture?
    - I used RNA Spike-Ins, but I did not expect this to cause a problem. It's just a little RNA in molecular-pure water.

    I Qubited the supernatant that I'd saved from the first wash (should be mostly rRNA in 1x Binding Buffer) and it actually had a little bit more RNA than I'd originally had in my sample. Possibly the additional RNA spike-in could account for there being slightly more RNA.

    Should I try redoing this with the supernatant from a couple of the samples, using the "old" beads I used last week that were fine? Should I consider A/B testing these new beads?

    Thanks for any advice you can provide.

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:26 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...